Showing 18,741 - 18,760 results of 105,386 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.42s Refine Results
  1. 18741

    Transmission electron micrographs of step 5 spermatids. by Yonggang Lu (358237)

    Published 2017
    “…<p><b>(A)</b> As the nuclear size (N) of step 5 spermatids decreases, the decondensed chromosomes are aggregated into a retiform pattern. …”
  2. 18742
  3. 18743
  4. 18744
  5. 18745

    vFLIP is not visible in cells expressing RTA. by Elana S. Ehrlich (532800)

    Published 2014
    “…<p>vFLIP expression is decreased in 293T cells cotransfected with RTA. 293T cells were transfected with myc tagged vFLIP and RTA where indicated. vFLIP was detected with anti-myc antibody (Millipore) followed by a rhodamine conjugated secondary antibody (Jackson ImmunoResearch). …”
  6. 18746

    A Family of Vanadate Esters of Monoionized and Diionized Aromatic 1,2-Diols: Synthesis, Structure, and Redox Activity by Bharat Baruah (1345038)

    Published 2002
    “…In solution each ester gives rise to a single <sup>51</sup>V NMR signal (no diastereoisomers), which generally shifts downfield with a decrease in the ester LMCT band energy. …”
  7. 18747

    Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

    Published 2012
    “…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”
  8. 18748
  9. 18749
  10. 18750

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  11. 18751

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  12. 18752

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  13. 18753

    Conservation of superfamilies within five Asgard proteomes. by Steven Russum (10475294)

    Published 2021
    “…This figure was generated using Anvi’o [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref160" target="_blank">160</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref161" target="_blank">161</a>].…”
  14. 18754

    Time courses of HA-GLUT4-eGFP intensity and microtubule density increase. by Jennine M. Dawicki-McKenna (142096)

    Published 2012
    “…(B) Nocodazole pre-treatment decreases the fold change in GLUT4 intensity in response to insulin. …”
  15. 18755

    Social robot PIO (version 3.5). by Jun-Seo Lim (21161776)

    Published 2025
    “…The difference between the two groups was statistically significant (<i>t</i> = 3.94, <i>p</i><.001). Depression decreased -0.7±3.48 in the experimental group, from 5.9±4.74 before intervention to 5.2±4.65 after intervention, and decreased by -0.2±3.42, from 6.5±4.69 before intervention to 6.4±4.08 after intervention, in the control group, but the difference between the two groups was not statistically significant (<i>z</i> = -0.59, <i>p</i> =.557). …”
  16. 18756

    The 5hmrC modified mRNAs. by Badri Nath Singh (18004418)

    Published 2024
    “…<p><b>A.</b> Volcano plot of mRNAs that are increased (green) or decreased (red) relative to wildtype levels in <i>Tet</i><sup><i>null</i></sup> LBF preparations; <b>B.…”
  17. 18757
  18. 18758

    TMD-5 intrinsic Trp fluorescence assay. by Xiaohui Wang (19899)

    Published 2012
    “…(b), Pentamidine decreases Trp emission fluorescence intensity of TMD-5 in 150 µM C14 betaine and 50 mM HEPES (pH = 7.4) buffer in a dose-dependent manner. …”
  19. 18759

    Inhibition correlates with cellular PmV levels. by Luca Gambini (826027)

    Published 2015
    “…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
  20. 18760

    MCPyV circALTO can be translated. by Rong Yang (107028)

    Published 2021
    “…<p>(A) CircALTOs do not inhibit MCPyV miRNA function in vitro. 293 cells were transfected with <i>Renilla</i> luciferase reporter with a 300 nucleotide region complementary to the MCPyV miRNA and the indicated plasmids including a MCPyV-miRNA-M1 expression plasmid (derived from isolate MCV350), pCDNA3.1 control vector, pCDNA circALTO1 (pcircALTO1) or pCDNA circALTO2 (pcircALTO2) expression plasmid. …”